<DOC>
	<DOCNO>NCT01164956</DOCNO>
	<brief_summary>The overall aim pilot study conduct combine N-of-1 trial ( N-1-T ) MPH ( methylphenidate ) amelioration fatigue child cancer , evaluate N-1-T design individual clinical decision make clinical trial symptom management pediatric oncology patient .</brief_summary>
	<brief_title>Methylphenidate Cancer-Related Fatigue</brief_title>
	<detailed_description>- Because one know study option best , participant receive liquid MPH day placebo day . We compare participant feel MPH day feel placebo day determine whether MPH make difference . - Participants take 3 day MPH row 3 day placebo row , make one study treatment pair . Participants receive total 3 study treatment pair . - On day participant take MPH placebo , answer one question ask rate fatigue . They also ask complete study drug diary well sleep diary . - After every 3 day either MPH placebo , participant complete additional survey fatigue , symptom , possible side effect MPH .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Participants must receive cancerdirected treatment DanaFarber Cancer Institute/Children 's Hospital Boston advance cancer 721 year old Laboratory value outline protocol Negative pregnancy test ( female childbearing potential ) Child least one parent/legal guardian speak write knowledge English Participant approximately ageappropriate knowledge English able understand complete singleitem Likert scale rating fatigue Baseline pedsFACITF score 20 great Able reliably take liquid enterally Physical examination include measurement pulse blood pressure conduct within past 14 day If child opioid analgesic , primary oncologist anticipate need increase opioid study Opioid dose stable least 5 day immediately prior enrollment No initiation change dose benzodiazepine sedative/hypnotic drug week prior enrollment forseeable initiation change study If currently SSRI , SNRI , tricyclic antidepressant , stable dose past week Participant telephone access communication study team regard potential dose adjustment provide telephone number alterative phone number Participant regard primary oncologist high likelihood death within 30 day Diagnosis brain tumor , metastatic disease brain , current active CNS leukemia Known history glaucoma Receiving palliative sedation Receipt MPH psychostimulant , alphaadrenergic medication , neuroleptic , lithium , monoamine oxidase inhibitor , procarbazine coumadin 14 day prior enrollment Significant GI disturbance would impair absorption drug History alcohol substance abuse subject . Subjects living household member history alcohol substance abuse may exclude investigator feel risk study medication abuse divert Documented history psychotic bipolar disorder , delirium , major depression , suicidal ideation , aggressive behavior necessitate psychiatric care , psychiatric condition require urgent psychiatric evaluation immediate initiation pharmacotherapy History tic Tourette 's syndrome Prior history adverse reaction MPH Uncontrolled hypertension Cardiomyopathy , serious structural cardiac abnormality , history following : ventricular arrhythmia , myocardial infarction , rheumatic fever , spontaneous unexplained syncope , exerciseinduced syncope , exerciseinduced chest pain . Family history ventricular arrhythmia , sudden unexplained event require resuscitation sudden death age 30 year , know cardiac arrhythmia , hypertrophic cardiomyopathy , dilate cardiomyopathy . Concurrent participation study prohibit enrollment trial involve cancerdirected symptomdirected therapy , without approval study PI Prior current medical condition , opinion PI , could exacerbate MPH Pregnant breastfeed woman HIVpositive individual combination antiretroviral therapy Treatment fatigue medication herbal supplement fatigue 14 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>methylphenidate</keyword>
	<keyword>fatigue</keyword>
</DOC>